(Q35621629)

9 August 2017

1 reference

title

Clinical virology of hepatitis B virus infection (English)

1 reference

9 August 2017

0 references

1 reference

Giovanni Raimondo

1

1 reference

9 August 2017

Teresa Pollicino

series ordinal

2

1 reference

9 August 2017

Giovanni Squadrito

series ordinal

3

1 reference

9 August 2017

publication date

1 January 2003

1 reference

9 August 2017

published in

Journal of Hepatology

1 reference

9 August 2017

volume

39 Suppl 1

1 reference

9 August 2017

page(s)

S26-30

1 reference

Kinetics of acute hepatitis B virus infection in humans.

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900135-1

7 January 2021

A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900135-1

7 January 2021

Pre-S2 defective hepatitis B virus infection in patients with fulminant hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900135-1

7 January 2021

Quantification of intrahepatic hepatitis B virus (HBV) DNA in patients with chronic HBV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900135-1

7 January 2021

Hepatitis B virus replication modulates pathogenesis of hepatitis D virus in chronic hepatitis D.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900135-1

7 January 2021

Hepatitis C Virus Infection in Chronic Hepatitis B Virus Carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900135-1

7 January 2021

Clinical and virological profiles in patients with multiple hepatitis virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900135-1

7 January 2021

Coinfection of hepatitis C virus in patients with chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900135-1

7 January 2021

Characteristics of patients with dual infection by hepatitis B and C viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900135-1

7 January 2021

Coinfection with hepatitis B and C or B, C and delta viruses results in severe chronic liver disease and responds poorly to interferon-alpha treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900135-1

7 January 2021

Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900135-1

7 January 2021

Long-term results with interferon therapy in chronic type B hepatitis: a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900135-1

7 January 2021

Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900135-1

7 January 2021

Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900135-1

7 January 2021

Virological profiles in patients with chronic hepatitis C and overt or occult HBV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900135-1

7 January 2021

Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900135-1

7 January 2021

Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900135-1

7 January 2021

Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900135-1

7 January 2021

Hepatitis B virus (HBV) markers and HBV-DNA in serum and liver tissue of patients with acute exacerbation of chronic type B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900135-1

7 January 2021

Fluctuations in viremia, aminotransferases and IgM antibody to hepatitis B core antigen in chronic hepatitis B patients with disease exacerbations.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900135-1

7 January 2021

A new hepatitis B virus variant in a chronic carrier with multiple episodes of viral reactivation and acute hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900135-1

7 January 2021

Quantitative analysis of IgM anti-HBc in chronic hepatitis B patients using a new “gray-zone” for the evaluation of “borderline” values

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900135-1

7 January 2021

Occult hepatitis B virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900135-1

7 January 2021

Occult hepatitis B virus infection and liver disease: fact or fiction?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900135-1

7 January 2021

Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900135-1

7 January 2021

Occult hepatitis B virus infection: a hidden menace?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900135-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900135-1

1 reference

7 January 2021

Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900135-1

7 January 2021

Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900135-1

7 January 2021

The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900135-1

7 January 2021

Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900135-1

7 January 2021

Demonstration of hepatitis B virus DNA by polymerase chain reaction in the serum and the liver after spontaneous or therapeutically induced HBeAg to anti-HBe or HBsAg to anti-HBs seroconversion in patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900135-1

7 January 2021

Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC).

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900135-1

7 January 2021

Hepatocellular carcinoma in woodchuck hepatitis virus-infected woodchucks: presence of viral DNA in tumor tissue from chronic carriers and animals serologically recovered from acute infections

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900135-1

7 January 2021

Long-lasting memory T cell responses following self-limited acute hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900135-1

7 January 2021

The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900135-1

7 January 2021

Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900135-1

7 January 2021

Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900135-1

7 January 2021

10.1016/S0168-8278(03)00135-1

Identifiers

DOI

1 reference

9 August 2017

1 reference